These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 25812014)

  • 1. Involvement of DNA-PKcs in the type I IFN response to CpG-ODNs in conventional dendritic cells in TLR9-dependent or -independent manners.
    Ma C; Spies NP; Gong T; Jones CX; Chu WM
    PLoS One; 2015; 10(3):e0121371. PubMed ID: 25812014
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Involvement of DNA-PKcs in the IL-6 and IL-12 response to CpG-ODN is mediated by its interaction with TRAF6 in dendritic cells.
    Ma C; Muranyi M; Chu CH; Zhang J; Chu WM
    PLoS One; 2013; 8(3):e58072. PubMed ID: 23533581
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The roles of Toll-like receptor 9, MyD88, and DNA-dependent protein kinase catalytic subunit in the effects of two distinct CpG DNAs on dendritic cell subsets.
    Hemmi H; Kaisho T; Takeda K; Akira S
    J Immunol; 2003 Mar; 170(6):3059-64. PubMed ID: 12626561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CpG-induced tyrosine phosphorylation occurs via a TLR9-independent mechanism and is required for cytokine secretion.
    Sanjuan MA; Rao N; Lai KT; Gu Y; Sun S; Fuchs A; Fung-Leung WP; Colonna M; Karlsson L
    J Cell Biol; 2006 Mar; 172(7):1057-68. PubMed ID: 16567503
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA-PKcs, but not TLR9, is required for activation of Akt by CpG-DNA.
    Dragoi AM; Fu X; Ivanov S; Zhang P; Sheng L; Wu D; Li GC; Chu WM
    EMBO J; 2005 Feb; 24(4):779-89. PubMed ID: 15678105
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective control of type I IFN induction by the Rac activator DOCK2 during TLR-mediated plasmacytoid dendritic cell activation.
    Gotoh K; Tanaka Y; Nishikimi A; Nakamura R; Yamada H; Maeda N; Ishikawa T; Hoshino K; Uruno T; Cao Q; Higashi S; Kawaguchi Y; Enjoji M; Takayanagi R; Kaisho T; Yoshikai Y; Fukui Y
    J Exp Med; 2010 Apr; 207(4):721-30. PubMed ID: 20231379
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Species-Specific Minimal Sequence Motif for Oligodeoxyribonucleotides Activating Mouse TLR9.
    Pohar J; Lainšček D; Fukui R; Yamamoto C; Miyake K; Jerala R; Benčina M
    J Immunol; 2015 Nov; 195(9):4396-405. PubMed ID: 26416273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endosomal translocation of CpG-oligodeoxynucleotides inhibits DNA-PKcs-dependent IL-10 production in macrophages.
    Yotsumoto S; Saegusa K; Aramaki Y
    J Immunol; 2008 Jan; 180(2):809-16. PubMed ID: 18178819
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin 1 receptor signaling regulates DUBA expression and facilitates Toll-like receptor 9-driven antiinflammatory cytokine production.
    González-Navajas JM; Law J; Nguyen KP; Bhargava M; Corr MP; Varki N; Eckmann L; Hoffman HM; Lee J; Raz E
    J Exp Med; 2010 Dec; 207(13):2799-807. PubMed ID: 21115691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential effects of CpG DNA on IFN-beta induction and STAT1 activation in murine macrophages versus dendritic cells: alternatively activated STAT1 negatively regulates TLR signaling in macrophages.
    Schroder K; Spille M; Pilz A; Lattin J; Bode KA; Irvine KM; Burrows AD; Ravasi T; Weighardt H; Stacey KJ; Decker T; Hume DA; Dalpke AH; Sweet MJ
    J Immunol; 2007 Sep; 179(6):3495-503. PubMed ID: 17785783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CpG-B oligodeoxynucleotides inhibit TLR-dependent and -independent induction of type I IFN in dendritic cells.
    Liu YC; Gray RC; Hardy GA; Kuchtey J; Abbott DW; Emancipator SN; Harding CV
    J Immunol; 2010 Apr; 184(7):3367-76. PubMed ID: 20181884
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deoxynucleic acids from Cryptococcus neoformans activate myeloid dendritic cells via a TLR9-dependent pathway.
    Nakamura K; Miyazato A; Xiao G; Hatta M; Inden K; Aoyagi T; Shiratori K; Takeda K; Akira S; Saijo S; Iwakura Y; Adachi Y; Ohno N; Suzuki K; Fujita J; Kaku M; Kawakami K
    J Immunol; 2008 Mar; 180(6):4067-74. PubMed ID: 18322216
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distinct responses of lung and spleen dendritic cells to the TLR9 agonist CpG oligodeoxynucleotide.
    Chen L; Arora M; Yarlagadda M; Oriss TB; Krishnamoorthy N; Ray A; Ray P
    J Immunol; 2006 Aug; 177(4):2373-83. PubMed ID: 16887999
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NCoR1 fine-tunes type-I IFN response in cDC1 dendritic cells by directly regulating Myd88-IRF7 axis under TLR9.
    Ahad A; Smita S; Mishra GP; Biswas VK; Sen K; Gupta B; Garcin D; Acha-Orbea H; Raghav SK
    Eur J Immunol; 2020 Dec; 50(12):1959-1975. PubMed ID: 32644192
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Guanine-modified inhibitory oligonucleotides efficiently impair TLR7- and TLR9-mediated immune responses of human immune cells.
    Römmler F; Hammel M; Waldhuber A; Müller T; Jurk M; Uhlmann E; Wagner H; Vollmer J; Miethke T
    PLoS One; 2015; 10(2):e0116703. PubMed ID: 25695778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential contribution of osteoclast- and osteoblast-lineage cells to CpG-oligodeoxynucleotide (CpG-ODN) modulation of osteoclastogenesis.
    Amcheslavsky A; Hemmi H; Akira S; Bar-Shavit Z
    J Bone Miner Res; 2005 Sep; 20(9):1692-9. PubMed ID: 16059640
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel role for HMGB1 in TLR9-mediated inflammatory responses to CpG-DNA.
    Ivanov S; Dragoi AM; Wang X; Dallacosta C; Louten J; Musco G; Sitia G; Yap GS; Wan Y; Biron CA; Bianchi ME; Wang H; Chu WM
    Blood; 2007 Sep; 110(6):1970-81. PubMed ID: 17548579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spatiotemporal regulation of MyD88-IRF-7 signalling for robust type-I interferon induction.
    Honda K; Ohba Y; Yanai H; Negishi H; Mizutani T; Takaoka A; Taya C; Taniguchi T
    Nature; 2005 Apr; 434(7036):1035-40. PubMed ID: 15815647
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blimp-1-Mediated Pathway Promotes Type I IFN Production in Plasmacytoid Dendritic Cells by Targeting to Interleukin-1 Receptor-Associated Kinase M.
    Ko YA; Chan YH; Liu CH; Liang JJ; Chuang TH; Hsueh YP; Lin YL; Lin KI
    Front Immunol; 2018; 9():1828. PubMed ID: 30131810
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CpG-B ODNs potently induce low levels of IFN-alphabeta and induce IFN-alphabeta-dependent MHC-I cross-presentation in DCs as effectively as CpG-A and CpG-C ODNs.
    Gray RC; Kuchtey J; Harding CV
    J Leukoc Biol; 2007 Apr; 81(4):1075-85. PubMed ID: 17227820
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.